Scientific interest in drug-induced mystical experiences reemerged in the 1990s. This warrants reexamining the philosophical issues surrounding such studies: Do psychedelic drugs cause mystical experiences? Are drug-induced experiences the same in nature as other mystical experiences? Does the fact that mystical experiences can be induced by drugs invalidate or validate mystical cognitive claims? Those questions will be examined here. An overview of the scientific examination of drug-induced mystical experiences is included, as is a brief overview of the history of the (...) use of psychedelic drugs in religion. (shrink)

Botanical preparations used by shamans in rituals for divination, prophecy, and ecstasy contain widely different psychoactive compounds, which are incorrectly classified under a single denomination such as “hallucinogens,” “psychedelics,” or “entheogens.” Based on extensive ethnopharmacological search, I proposed a psychopharmacological classification of magic plants in 1979. This paper re-evaluates this taxonomy in the context of consciousness research. Several groups of psychodysleptic magic plants are proposed: (1) hallucinogens—psilocybin mushrooms, mescaline cacti, dimethyltryptamine snuffs, and the synthetic ergoline lysergic acid diethylamide induce strong (...) perceptual changes, affective intensification, and cognitive enhancement. Their ethnobotanical uses include long lasting divination rituals, prophecy, and sacramental practice. (2) Trance-inducers—ergoline Convolvulaceae and South American Banisteriopsis produce quietness, abstraction, lethargy, mild sensorial and cognitive changes, and salient visual imagery changes used in trance rituals and specific divination practices. (3) Cognodysleptics—marijuana (tetrahydrocannabinol) and other terpene-containing plants induce changes in thought, imagination, and affective functions and are used in short-term divination or oneiromancy. (4) Deliriants—tropane-containing Solanaceae, wild tobacco, and Amanita muscaria (muscimol) induce a delirium characterized by dim and clouded consciousness, stupor, confusion, disorientation, perception distortion, difficulties in recollection, anxiety, irritability, excitation, and behavioral disorganization employed in sorcery, purification, or exorcism rituals. The core mental effects required for a drug to be used in shamanistic rituals include light-headedness, enhanced imagery, and experience intensification. This constellation was the reason why, in his classification of psychoactive compounds, the pioneer German psychopharmacologist Louis Lewin established in 1924 a group of drugs under the appropriate name of Phantastica. (shrink)

This is a bibliography of books and articles on consciousness in philosophy, cognitive science, and neuroscience over the last 30 years. There are three main sections, devoted to monographs, edited collections of papers, and articles. The first two of these sections are each divided into three subsections containing books in each of the main areas of research. The third section is divided into 12 subsections, with 10 subject headings for philosophical articles along with two additional subsections for articles in cognitive (...) science and neuroscience. Of course the division is somewhat arbitrary, but I hope that it makes the bibliography easier to use. This bibliography has first been compiled by Thomas Metzinger and David Chalmers to appear in print in two philosophical anthologies on conscious experience . From 1995 onwards it has been continuously updated by Thomas Metzinger, and now is freely available as a PDF-, RTF-, or HTML-file. This bibliography mainly attempts to cover the Anglo-Saxon and German debates, in a non-annotated, fully formatted way that makes it easy to "cut and paste" from the original file. To a certain degree this bibliography also contains items in other languages than English and German - all submissions in other languages are welcome. Last update of current version: July 13th, 2001. (shrink)

Our goal is to investigate the biological correlates of the first-person experience of time or phenomenal time. ‘Time’ differs in various domains, such as (i) physical time (e.g., clock time), (ii) biological time, such as the suprachiasmatic nucleus, and (iii) the perceptual rate of time. One psychophysical-measure of the perceptual rate is the critical flicker frequency (CFF), in which a flashing light is perceived as unchanging. Focusing on the inability to detect change, as in CFF, may give us insight into (...) phenomenal time. CFF varies from 24 Hz for dim light and 60 Hz in bright light and is lower for colored lights. We propose that problem of the phenomenal time can be addressed using two contrasting but complementary approaches (inability to detect changes vs. ability to detect changes): (1) The soliton-catalytic model that entails invariant quantum coherent state for temporal frequencies (TFs) >= CFF, where flickering light is perceived as unchanging, similar to a Bose-Einstein condensate (BEC). (2) Temporal frequency tuned mechanisms model, which starts with ability to detect changes for TFs < CFF and then their sensitivities decreases to zero at CFF. For a subject who has CFF of 60 Hz, the duration of one cycle or time-period of the flickering light is approximately 16.7 ms. Phenomenal time may be quantized into ‘subjective occasions of experience’ (SE), which arise out of the interaction of the individual with situation (environment). Pioneering work examining the complex interaction of neurons suggests the possibility that macroscopic quantum states similar to a BEC may also occur in the brain (Davia, 2006; Freeman & Vitiello, 2006; Georgiev, 2004; Vimal & Davia, 2008) . (shrink)